Literature DB >> 33749308

Segmental Cardiac Radiation Dose Determines Magnitude of Regional Cardiac Dysfunction.

Siddharth J Trivedi1,2, Simon Tang3,4,5, Karen Byth6,7, Luke Stefani1, Queenie Lo3,8, James Otton3,9, Michael Jameson3,4,10, David Tran9, Vikneswary Batumalai3,4,10, Lois Holloway3,4,10, Geoff P Delaney3,4,10, Eng-Siew Koh3,4,10, Liza Thomas1,2,3.   

Abstract

Background Subclinical left ventricular dysfunction detected by 2-dimensional global longitudinal strain post breast radiotherapy has been described in patients with breast cancer. We hypothesized that left ventricular dysfunction postradiotherapy may be site specific, based on differential segmental radiotherapy dose received. Methods and Results Transthoracic echocardiograms were performed at baseline, 6 weeks, and 12 months postradiotherapy on 61 chemotherapy-naïve women with left-sided breast cancer undergoing tangential breast radiotherapy. Radiation received within basal, mid, and apical regions for the 6 left ventricular walls was quantified from the radiotherapy treatment planning system. Anterior, anteroseptal, and anterolateral walls received the highest radiation doses, while inferolateral and inferior walls received the lowest. There was a progressive increase in the radiation dose received from basal to apical regions. At 6 weeks, the most significant percentage deterioration in strain was seen in the apical region, with greatest reductions in the anterior wall followed by the anteroseptal and anterolateral walls, with a similar pattern persisting at 12 months. There was a within-patient dose-response association between the segment-specific percentage deterioration in strain at 6 weeks and 12 months and the radiation dose received. Conclusions Radiotherapy for left-sided breast cancer causes differential segmental dysfunction, with myocardial segments that receive the highest radiation dose demonstrating greatest strain impairment. Percentage deterioration in strain observed 6 weeks postradiotherapy persisted at 12 months and demonstrated a dose-response relationship with radiotherapy dose received. Radiotherapy-induced subclinical cardiac dysfunction is of importance because it could be additive to chemotherapy-related cardiotoxicity in patients with breast cancer. Long-term outcomes in patients with asymptomatic strain reduction require further investigation.

Entities:  

Keywords:  LV dysfunction; breast cancer; cardiotoxicity; global longitudinal strain; radiotherapy; strain echocardiography

Year:  2021        PMID: 33749308     DOI: 10.1161/JAHA.120.019476

Source DB:  PubMed          Journal:  J Am Heart Assoc        ISSN: 2047-9980            Impact factor:   5.501


  3 in total

Review 1.  Radiation-Induced Heart Disease.

Authors:  Juan A Quintero-Martinez; Sandra N Cordova-Madera; Hector R Villarraga
Journal:  J Clin Med       Date:  2021-12-28       Impact factor: 4.241

Review 2.  Radiotherapy-Induced Cardiotoxicity: The Role of Multimodality Cardiovascular Imaging.

Authors:  Tomaž Podlesnikar; Boštjan Berlot; Jure Dolenc; Katja Goričar; Tanja Marinko
Journal:  Front Cardiovasc Med       Date:  2022-07-28

3.  Molecular Changes In Cardiac Tissue As A New Marker To Predict Cardiac Dysfunction Induced By Radiotherapy.

Authors:  Sónia Ribeiro; Ana Rita Simões; Filipe Rocha; Inês Sofia Vala; Ana Teresa Pinto; Augusto Ministro; Esmeralda Poli; Isabel Maria Diegues; Filomena Pina; Mohamed Amine Benadjaoud; Stephane Flamant; Radia Tamarat; Hugo Osório; Diogo Pais; Diogo Casal; Fausto José Pinto; Rune Matthiesen; Manuela Fiuza; Susana Constantino Rosa Santos
Journal:  Front Oncol       Date:  2022-07-26       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.